These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 18607400)
1. Does treatment with calcitriol improve survival in predialysis patients with chronic kidney disease? Patel TV; Singh AK Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):484-5. PubMed ID: 18607400 [TBL] [Abstract][Full Text] [Related]
2. Association of activated vitamin D treatment and mortality in chronic kidney disease. Kovesdy CP; Ahmadzadeh S; Anderson JE; Kalantar-Zadeh K Arch Intern Med; 2008 Feb; 168(4):397-403. PubMed ID: 18299495 [TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
4. Assessing the benefits and harms of statin treatment in patients with chronic kidney disease. Bogaert YE; Chonchol M Nat Clin Pract Nephrol; 2008 Sep; 4(9):470-1. PubMed ID: 18628740 [TBL] [Abstract][Full Text] [Related]
6. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Schumock GT; Andress DL; Marx SE; Sterz R; Joyce AT; Kalantar-Zadeh K Nephron Clin Pract; 2009; 113(1):c54-61. PubMed ID: 19590235 [TBL] [Abstract][Full Text] [Related]
7. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Tentori F; Albert JM; Young EW; Blayney MJ; Robinson BM; Pisoni RL; Akiba T; Greenwood RN; Kimata N; Levin NW; Piera LM; Saran R; Wolfe RA; Port FK Nephrol Dial Transplant; 2009 Mar; 24(3):963-72. PubMed ID: 19028748 [TBL] [Abstract][Full Text] [Related]
8. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients]. Inaguma D; Tatematsu M Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827 [TBL] [Abstract][Full Text] [Related]
9. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Heinz J; Kropf S; Luley C; Dierkes J Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080 [TBL] [Abstract][Full Text] [Related]
10. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study. Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P; Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686 [TBL] [Abstract][Full Text] [Related]
11. Malnutrition-Inflammation Score for risk stratification of patients with CKD: is it the promised gold standard? Rambod M; Kovesdy CP; Kalantar-Zadeh K Nat Clin Pract Nephrol; 2008 Jul; 4(7):354-5. PubMed ID: 18523431 [TBL] [Abstract][Full Text] [Related]
12. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585 [TBL] [Abstract][Full Text] [Related]
13. The risk of gallbladder stone formation is increased in patients with predialysis chronic kidney disease but not those undergoing chronic hemodialysis therapy. Kazama JJ; Kazama S; Koda R; Yamamoto S; Narita I; Gejyo F Nephron Clin Pract; 2009; 111(3):c167-72. PubMed ID: 19194106 [TBL] [Abstract][Full Text] [Related]
14. How should peritoneal-dialysis-associated peritonitis be treated? Piraino B; Bender F Nat Clin Pract Nephrol; 2008 Jul; 4(7):356-7. PubMed ID: 18493237 [TBL] [Abstract][Full Text] [Related]
15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
16. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial. Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D deficiency and associated factors in hemodialysis patients. Jean G; Charra B; Chazot C J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733 [TBL] [Abstract][Full Text] [Related]
18. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation. Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397 [TBL] [Abstract][Full Text] [Related]
19. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609 [TBL] [Abstract][Full Text] [Related]
20. [Anemia in chronic kidney disease and its cardiovascular implications]. Cases A; Coll E; Collado S Med Clin (Barc); 2009 May; 132 Suppl 1():38-42. PubMed ID: 19460479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]